Salim S. Virani

156.5k total citations · 18 hit papers
734 papers, 25.2k citations indexed

About

Salim S. Virani is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Economics and Econometrics. According to data from OpenAlex, Salim S. Virani has authored 734 papers receiving a total of 25.2k indexed citations (citations by other indexed papers that have themselves been cited), including 352 papers in Cardiology and Cardiovascular Medicine, 308 papers in Surgery and 147 papers in Economics and Econometrics. Recurrent topics in Salim S. Virani's work include Lipoproteins and Cardiovascular Health (239 papers), Health Systems, Economic Evaluations, Quality of Life (118 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (104 papers). Salim S. Virani is often cited by papers focused on Lipoproteins and Cardiovascular Health (239 papers), Health Systems, Economic Evaluations, Quality of Life (118 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (104 papers). Salim S. Virani collaborates with scholars based in United States, Pakistan and Australia. Salim S. Virani's co-authors include Roger S. Blumenthal, Donald M. Lloyd‐Jones, Erin D. Michos, Christie M. Ballantyne, Sidney C. Smith, Amit Khera, Michael D. Miedema, John W. McEvoy, Joseph Yeboah and Michelle A. Albert and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Salim S. Virani

685 papers receiving 24.7k citations

Hit Papers

2019 ACC/AHA Guideline on the Primary P... 2011 2026 2016 2021 2019 2019 2019 2019 2011 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
    2019 3.6k citations Roger S. Blumenthal, Erin D. Michos et al. Circulation profile →
  2. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
    2019 3.0k citations Roger S. Blumenthal, Erin D. Michos et al. Circulation profile →
  3. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
    2019 1.2k citations Roger S. Blumenthal, Erin D. Michos et al. profile →
  4. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
    2019 804 citations Roger S. Blumenthal, Erin D. Michos et al. profile →
  5. Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study
    2011 561 citations Vijay Nambi, Salim S. Virani et al. Circulation profile →
  6. Small Dense Low-Density Lipoprotein-Cholesterol Concentrations Predict Risk for Coronary Heart Disease
    2014 385 citations Wensheng Sun, Rhiannon Dodge et al. profile →
  7. The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk
    2018 371 citations Salim S. Virani, Michael D. Shapiro et al. profile →
  8. Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology
    2019 368 citations Salim S. Virani, Roger S. Blumenthal et al. Circulation profile →
  9. Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association
    2023 283 citations Josef Coresh, Salim S. Virani et al. Circulation profile →
  10. National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013
    2016 283 citations Javier Valero‐Elizondo, Salim S. Virani et al. profile →
  11. Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association
    2016 239 citations Salim S. Virani et al. Circulation profile →
  12. Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease
    2019 228 citations Fátima Rodríguez, Salim S. Virani et al. profile →
  13. Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis
    2021 222 citations Salim S. Virani, Roger S. Blumenthal et al. profile →
  14. Sex Differences in the Use of Statins in Community Practice
    2019 197 citations Salim S. Virani et al. profile →
  15. 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia
    2021 167 citations Salim S. Virani, Christie M. Ballantyne et al. profile →
  16. Ten things to know about ten cardiovascular disease risk factors
    2021 150 citations Erin D. Michos, Michael D. Shapiro et al. SHILAP Revista de lepidopterología profile →
  17. PM2.5 and Cardiovascular Health Risks
    2023 76 citations Chayakrit Krittanawong, Salim S. Virani et al. Current Problems in Cardiology profile →
  18. Family income and cardiovascular disease risk in American adults
    2023 53 citations Abdul Mannan Khan Minhas, Vardhmaan Jain et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salim S. Virani United States 61 11.0k 8.3k 4.8k 3.1k 2.8k 734 25.2k
Vera Bittner United States 76 13.6k 1.2× 6.8k 0.8× 5.9k 1.2× 1.8k 0.6× 2.4k 0.8× 369 26.6k
Erin D. Michos United States 77 11.7k 1.1× 5.9k 0.7× 5.4k 1.1× 1.7k 0.5× 4.7k 1.6× 689 30.5k
Patrick E. McBride United States 37 12.5k 1.1× 10.5k 1.3× 7.8k 1.6× 3.7k 1.2× 3.1k 1.1× 119 29.9k
Guy De Backer Belgium 64 12.3k 1.1× 7.5k 0.9× 5.6k 1.2× 2.7k 0.9× 2.7k 1.0× 304 24.3k
Karol E. Watson United States 55 8.0k 0.7× 8.1k 1.0× 4.4k 0.9× 2.9k 0.9× 1.6k 0.6× 216 22.7k
Amit Khera United States 61 9.9k 0.9× 6.5k 0.8× 4.8k 1.0× 1.3k 0.4× 2.4k 0.9× 210 22.3k
Daniel T. Lackland United States 57 12.1k 1.1× 3.7k 0.4× 4.3k 0.9× 1.8k 0.6× 3.5k 1.2× 270 24.3k
Luther T. Clark United States 38 7.6k 0.7× 8.6k 1.0× 7.5k 1.5× 2.6k 0.8× 2.9k 1.0× 102 22.5k
Jonathan Emberson United Kingdom 48 6.3k 0.6× 7.6k 0.9× 4.1k 0.8× 2.5k 0.8× 2.9k 1.0× 134 20.8k
Arno W. Hoes Netherlands 76 14.2k 1.3× 6.0k 0.7× 3.1k 0.7× 2.1k 0.7× 1.8k 0.6× 474 27.9k

Countries citing papers authored by Salim S. Virani

Since Specialization
Citations

This map shows the geographic impact of Salim S. Virani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salim S. Virani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salim S. Virani more than expected).

Fields of papers citing papers by Salim S. Virani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salim S. Virani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salim S. Virani. The network helps show where Salim S. Virani may publish in the future.

Co-authorship network of co-authors of Salim S. Virani

This figure shows the co-authorship network connecting the top 25 collaborators of Salim S. Virani. A scholar is included among the top collaborators of Salim S. Virani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salim S. Virani. Salim S. Virani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stabellini, Nickolas, Omar Mohamed Makram, Hisham Daoud, et al.. (2025). A novel machine learning-based cancer-specific cardiovascular disease risk score among patients with breast, colorectal, or lung cancer. JNCI Cancer Spectrum. 9(1). 2 indexed citations
2.
Abdelaziz, Ahmed, Ahmed Elshahat, Annalisa Filtz, et al.. (2025). Colchicine for secondary prevention in established ASCVD: a systematic review and meta-analysis. European Journal of Preventive Cardiology. 33(5). 788–790. 1 indexed citations
3.
Sheikh, Sana, Abdul Mannan Khan Minhas, Elizabeth M. Vaughan, et al.. (2024). A review of top cardiology and cardiovascular medicine journal guidelines regarding the use of generative artificial intelligence tools in scientific writing. Current Problems in Cardiology. 49(3). 102387–102387. 22 indexed citations
4.
Sayed, Ahmed, Elizabeth R. Stevens, Kosuke Tamura, et al.. (2024). Association between a diagnosis of diabetes mellitus and smoking abstinence: An analysis of the National Health Interview Survey (2006-2018). Preventive Medicine. 187. 108085–108085.
5.
Virani, Salim S., Fátima Rodríguez, Nathan D Wong, et al.. (2024). American society for preventive cardiology 2024 cardiovascular disease prevention: Highlights and key sessions. SHILAP Revista de lepidopterología. 21. 100919–100919.
6.
Coulter, Stephanie, et al.. (2024). Cardiovascular Disease Management With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Cardiology Primer. Texas Heart Institute Journal. 51(1). 3 indexed citations
7.
Pandey, Ambarish, Kershaw V. Patel, Matthew W. Segar, et al.. (2024). Association of High-Density Lipoprotein Parameters and Risk of Heart Failure. JACC Heart Failure. 12(7). 1242–1253. 5 indexed citations
8.
Fudim, Marat, Stephen J. Greene, Vijay Nambi, et al.. (2024). Ongoing and future clinical trials of device therapies for patients with heart failure. Current Problems in Cardiology. 49(11). 102805–102805. 1 indexed citations
9.
Jain, Vardhmaan, Mahmoud Al Rifai, Alka M. Kanaya, et al.. (2024). Association of cardiovascular health with subclinical coronary atherosclerosis progression among five racial and ethnic groups: The MASALA and MESA studies. Atherosclerosis. 392. 117522–117522. 3 indexed citations
10.
Ullah, Waqas, Salman Zahid, Yasar Sattar, et al.. (2023). Trends and Outcomes of Transcatheter Aortic Valve Implantation in Aortic Insufficiency: A Nationwide Readmission Database Analysis. Current Problems in Cardiology. 49(1). 102012–102012. 1 indexed citations
11.
Chunara, Rumi, Aysha Habib Khan, Afia Zafar, et al.. (2023). Prevalence of familial hypercholesterolemia in a country-wide laboratory network in Pakistan: 10-year data from 988, 306 patients. Progress in Cardiovascular Diseases. 79. 19–27. 4 indexed citations
12.
Javed, Zulqarnain, Isaac Acquah, Kobina Hagan, et al.. (2023). Low educational attainment is associated with higher all-cause and cardiovascular mortality in the United States adult population. BMC Public Health. 23(1). 900–900. 25 indexed citations
13.
Kianoush, Sina, Sana Sheikh, Chayakrit Krittanawong, et al.. (2023). The Association Between Race, Ethnicity and Sleep Quality and Duration: A National Health Interview Survey Study. Current Problems in Cardiology. 48(12). 102004–102004. 5 indexed citations
14.
Vaughan, Elizabeth M., Victor J. Cardenas, Wenyaw Chan, et al.. (2023). Implementation and Evaluation of a mHealth-Based Community Health Worker Feedback Loop for Hispanics with and at Risk for Diabetes. Journal of General Internal Medicine. 39(2). 229–238. 7 indexed citations
15.
Hao, Wenting, Yan Ma, Nipun Shrestha, et al.. (2023). Number of Live Births, Age at the Time of Having a Child, Span of Births and Risk of Dementia: A Population-Based Cohort Study of 253,611 U.K. Women. Journal of Women s Health. 32(6). 680–692. 10 indexed citations
16.
Gregg, L. Parker, Peter Van Buren, Subhash Banerjee, et al.. (2022). Natriuretic Peptides, Extracellular Volume, and Subclinical Cardiovascular Changes in Chronic Kidney Disease Stages 1–3: A Pilot Study. Journal of Investigative Medicine. 70(7). 1520–1528. 2 indexed citations
17.
Saeed, Anum, Salim S. Virani, Suresh Mulukutla, & Clara K Chow. (2021). Dyslipidemia and Cardiovascular Disease Prevention in South Asians: A Review and Discussion of Causes, Challenges and Management Strategies. Current Diabetes Reviews. 17(9). e011221190238–e011221190238. 9 indexed citations
18.
19.
Lee, David W., Prashant Kaul, George A. Stouffer, et al.. (2017). Abstract 19292: Cardiovascular Secondary Prevention Therapies are Underprescribed in Patients With Peripheral Artery Disease: Findings From the NCDR PINNACLE Registry. Circulation. 1 indexed citations
20.
Virani, Salim S., Wensheng Sun, Rhiannon Dodge, et al.. (2013). Abstract 14835: Carotid Artery Plaque Burden and Characteristics and Subsequent Risk of Incident Cardiovascular Events: The Atherosclerosis Risk in Communities (ARIC) Carotid Magnetic Resonance Imaging Study. Circulation. 128. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vera Bittner Breakdown of academic impact, for papers by Erin D. Michos Breakdown of academic impact, for papers by Patrick E. McBride Breakdown of academic impact, for papers by Guy De Backer Breakdown of academic impact, for papers by Karol E. Watson Breakdown of academic impact, for papers by Amit Khera Breakdown of academic impact, for papers by Daniel T. Lackland Breakdown of academic impact, for papers by Luther T. Clark Breakdown of academic impact, for papers by Jonathan Emberson Breakdown of academic impact, for papers by Arno W. Hoes
Rankless by CCL
2026